StoCastic
Acquisition in 2022
StoCastic is a healthcare enterprise software developer based in Towson, Maryland, founded in 2015. The company focuses on creating solutions that enhance value for both patients and healthcare organizations. Its software utilizes consulting bundles designed to improve operational performance, clinical workflows, teamwork, and organizational best practices. By implementing these solutions, StoCastic aims to help healthcare providers deliver more efficient and cost-effective care to their customers.
Lumigen
Acquisition in 2006
Lumigen specializes in the manufacture and marketing of chemiluminescent compounds utilized in life science research and medical diagnostics. The company produces a range of chemiluminescent reagents specifically designed for the clinical immunodiagnostics market. Its product offerings include tools for western blotting, alkaline phosphatase, horseradish peroxidase, and homogeneous immunoassays, which are essential in various applications, including life science research and human identity testing. Through its innovative solutions, Lumigen supports advancements in diagnostic techniques and research methodologies.
Agencourt Bioscience
Acquisition in 2005
Agencourt Bioscience Corporation provides nucleic acid purification products and genomic services for life science research in the United States and internationally. It offers DNA purification and RNA purification solutions. The company’s products include solid phase reversible immobilization (SPRI) reagents; a PCR1 purification system that delivers DNA; a dye-terminator removal process system; a paramagenetic bead-based plasmid purification system; and a genomic DNA isolation reagent kit. Its products also include Agencourt FormaPure system that provides a process for extracting nucleic acid from formalin-fixed and paraffin-embedded tissue samples; a tissue RNA extraction technology; accessories; and a suite of automation methods for SPRI paramagnetic bead-based reagents. In addition, the company offers DNA sequencing, resequencing and SNP discovery, library construction, bioinformatics, and sequencing pipeline services. It serves biotechnology, pharmaceutical, government, and academic research laboratories. Agencourt Bioscience Corporation has strategic alliances with Affymetrix Inc.; Amplicon Express, Inc.; Seradyn, Inc.; Invitrogen, Corp.; Integrated Genomics, Inc.; and Ambion, Inc. The company was founded in 2000 and is headquartered in Beverly, Massachusetts. It has offices in Australia, Canada, China, Eastern Europe, the Middle East, North Africa, France, Germany, Hong Kong, Italy, Japan, Mexico, the Netherlands, Singapore, South Africa, Sub-Saharan Africa, Spain, Sweden, Switzerland, Taiwan, Turkey, the United Kingdom, and the United States. As of June 30, 2005, Agencourt Bioscience Corporation was a subsidiary of Beckman Coulter, Inc.
Q3DM specializes in high throughput microscopy (HTM) technology aimed at enhancing drug discovery processes. The company offers innovative products and services focused on cell-based imaging, enabling researchers to overcome challenges associated with automating high-resolution imaging. By integrating high content screening with rapid data acquisition, Q3DM facilitates the production of statistically significant results, thereby providing valuable insights into complex biological processes.